Increased pregenual anterior cingulate glucose and lactate concentrations in major depressive disorder

J. Ernst, A. Hock, A. Henning, E. Seifritz, H. Boeker, S. Grimm

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

There is ample evidence that glucose metabolism in the pregenual anterior cingulate cortex (PACC) is increased in major depressive disorder (MDD), whereas it is still unknown whether glucose levels per se are also elevated. Elevated cerebrospinal fluid (CSF) lactate concentrations in MDD patients might indicate that increased glycolytical metabolization of glucose to lactate in astrocytes either alone or in conjunction with mitochondrial dysfunction results in an accumulation of lactate and contributes to pathophysiological mechanisms of MDD. However, until now, no study investigated in vivo PACC glucose and lactate levels in MDD. Proton magnetic resonance spectroscopy was therefore used to test the hypothesis that patients with MDD have increased PACC glucose and lactate levels. In 40 healthy and depressed participants, spectra were acquired from the PACC using a maximum echo J-resolved spectroscopy protocol. Results show significant increases of glucose and lactate in patients, which are also associated with depression severity. These findings indicate impaired brain energy metabolism in MDD with increased fraction of energy utilization via glycolysis and reduced mitochondrial oxidative clearance of lactate. Targeting these metabolic disturbances might affect the balance of metabolic pathways regulating neuronal energetics and result in an attenuation of the elevated basal activity of brain regions within the neural circuitry of depression.

Original languageEnglish (US)
Pages (from-to)113-119
Number of pages7
JournalMolecular Psychiatry
Volume22
Issue number1
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Fingerprint

Gyrus Cinguli
Major Depressive Disorder
Lactic Acid
Glucose
Depression
Brain
Glycolysis
Metabolic Networks and Pathways
Astrocytes
Energy Metabolism
Cerebrospinal Fluid
Spectrum Analysis
Healthy Volunteers

ASJC Scopus subject areas

  • Molecular Biology
  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience

Cite this

Increased pregenual anterior cingulate glucose and lactate concentrations in major depressive disorder. / Ernst, J.; Hock, A.; Henning, A.; Seifritz, E.; Boeker, H.; Grimm, S.

In: Molecular Psychiatry, Vol. 22, No. 1, 01.01.2017, p. 113-119.

Research output: Contribution to journalArticle

Ernst, J. ; Hock, A. ; Henning, A. ; Seifritz, E. ; Boeker, H. ; Grimm, S. / Increased pregenual anterior cingulate glucose and lactate concentrations in major depressive disorder. In: Molecular Psychiatry. 2017 ; Vol. 22, No. 1. pp. 113-119.
@article{92654b1be0594f908e5627a3bf1d22b1,
title = "Increased pregenual anterior cingulate glucose and lactate concentrations in major depressive disorder",
abstract = "There is ample evidence that glucose metabolism in the pregenual anterior cingulate cortex (PACC) is increased in major depressive disorder (MDD), whereas it is still unknown whether glucose levels per se are also elevated. Elevated cerebrospinal fluid (CSF) lactate concentrations in MDD patients might indicate that increased glycolytical metabolization of glucose to lactate in astrocytes either alone or in conjunction with mitochondrial dysfunction results in an accumulation of lactate and contributes to pathophysiological mechanisms of MDD. However, until now, no study investigated in vivo PACC glucose and lactate levels in MDD. Proton magnetic resonance spectroscopy was therefore used to test the hypothesis that patients with MDD have increased PACC glucose and lactate levels. In 40 healthy and depressed participants, spectra were acquired from the PACC using a maximum echo J-resolved spectroscopy protocol. Results show significant increases of glucose and lactate in patients, which are also associated with depression severity. These findings indicate impaired brain energy metabolism in MDD with increased fraction of energy utilization via glycolysis and reduced mitochondrial oxidative clearance of lactate. Targeting these metabolic disturbances might affect the balance of metabolic pathways regulating neuronal energetics and result in an attenuation of the elevated basal activity of brain regions within the neural circuitry of depression.",
author = "J. Ernst and A. Hock and A. Henning and E. Seifritz and H. Boeker and S. Grimm",
year = "2017",
month = "1",
day = "1",
doi = "10.1038/mp.2016.73",
language = "English (US)",
volume = "22",
pages = "113--119",
journal = "Molecular Psychiatry",
issn = "1359-4184",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Increased pregenual anterior cingulate glucose and lactate concentrations in major depressive disorder

AU - Ernst, J.

AU - Hock, A.

AU - Henning, A.

AU - Seifritz, E.

AU - Boeker, H.

AU - Grimm, S.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - There is ample evidence that glucose metabolism in the pregenual anterior cingulate cortex (PACC) is increased in major depressive disorder (MDD), whereas it is still unknown whether glucose levels per se are also elevated. Elevated cerebrospinal fluid (CSF) lactate concentrations in MDD patients might indicate that increased glycolytical metabolization of glucose to lactate in astrocytes either alone or in conjunction with mitochondrial dysfunction results in an accumulation of lactate and contributes to pathophysiological mechanisms of MDD. However, until now, no study investigated in vivo PACC glucose and lactate levels in MDD. Proton magnetic resonance spectroscopy was therefore used to test the hypothesis that patients with MDD have increased PACC glucose and lactate levels. In 40 healthy and depressed participants, spectra were acquired from the PACC using a maximum echo J-resolved spectroscopy protocol. Results show significant increases of glucose and lactate in patients, which are also associated with depression severity. These findings indicate impaired brain energy metabolism in MDD with increased fraction of energy utilization via glycolysis and reduced mitochondrial oxidative clearance of lactate. Targeting these metabolic disturbances might affect the balance of metabolic pathways regulating neuronal energetics and result in an attenuation of the elevated basal activity of brain regions within the neural circuitry of depression.

AB - There is ample evidence that glucose metabolism in the pregenual anterior cingulate cortex (PACC) is increased in major depressive disorder (MDD), whereas it is still unknown whether glucose levels per se are also elevated. Elevated cerebrospinal fluid (CSF) lactate concentrations in MDD patients might indicate that increased glycolytical metabolization of glucose to lactate in astrocytes either alone or in conjunction with mitochondrial dysfunction results in an accumulation of lactate and contributes to pathophysiological mechanisms of MDD. However, until now, no study investigated in vivo PACC glucose and lactate levels in MDD. Proton magnetic resonance spectroscopy was therefore used to test the hypothesis that patients with MDD have increased PACC glucose and lactate levels. In 40 healthy and depressed participants, spectra were acquired from the PACC using a maximum echo J-resolved spectroscopy protocol. Results show significant increases of glucose and lactate in patients, which are also associated with depression severity. These findings indicate impaired brain energy metabolism in MDD with increased fraction of energy utilization via glycolysis and reduced mitochondrial oxidative clearance of lactate. Targeting these metabolic disturbances might affect the balance of metabolic pathways regulating neuronal energetics and result in an attenuation of the elevated basal activity of brain regions within the neural circuitry of depression.

UR - http://www.scopus.com/inward/record.url?scp=84968583539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84968583539&partnerID=8YFLogxK

U2 - 10.1038/mp.2016.73

DO - 10.1038/mp.2016.73

M3 - Article

C2 - 27184123

AN - SCOPUS:84968583539

VL - 22

SP - 113

EP - 119

JO - Molecular Psychiatry

JF - Molecular Psychiatry

SN - 1359-4184

IS - 1

ER -